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Abstract
Background: Anxiety and depression are associated with substantial functional impairment. Prompt Mental Health
Care (PMHC), the Norwegian adaptation of IAPT is currently piloted across Norway, as a means to improve access to
evidence-based care for adults with anxiety disorders (including subthreshold cases) and minor to moderate
depression. The aims of the current paper were to examine the change in work status and functional status from
pre- to post-treatment and 12 months post-treatment among clients at the first 12 PMHC pilot sites, and whether
degree of change differed across sociodemographic characteristics.
Methods: A prospective cohort design was used, including working age clients receiving treatment between
October 2014 and December 2016 (n = 1446, participation rate = 61%). Work status and functional status were self-
reported, the latter by the Work and Social Adjustment Scale (WSAS). Changes in work status and WSAS score were
examined through multilevel models based on maximum likelihood estimation. Likelihood ratio tests were
performed to determine whether the interaction between time and the respective background variables were
statistically significant.
Results: A substantial increase in regular work participation was observed from pre- to post-treatment, which
further had increased at 12 months post-treatment. The increase was driven by a corresponding reduction in
proportion of clients working and receiving benefits (OR 0.38 [0.29–0.50] baseline to final treatment, OR = 0.19
[0.12–0.32] final treatment to 12-months post-treatment), while no statistically significant change was observed in
proportion out of work. Large improvement (ES = − 0.89) in WSAS score was observed from pre- to post treatment.
WSAS score at 12 months post-treatment remained at the post-treatment level.
Conclusions: Previous research has shown substantial symptom improvement among clients receiving treatment
in PMHC. The current findings indicate that PMHC might also be able to aid adults struggling with mild to
moderate anxiety and depression in returning to usual level of functioning. The degree to which the observed
improvements are attributable to the treatment need nonetheless to be confirmed in a trial including a control
group and with more complete follow-up data from registries.
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Background
Anxiety and depression are associated with substantial
functional impairment, impacting both private life and
the occupational sphere in terms of presenteeism and
absenteeism [1–6]. The functional impairment is
greater for these than many other common conditions,
such as back pain, diabetes and arthritis [7, 8]. Further,
function may also be impaired among workers with
subthreshold symptom levels [9, 10] and after remission
[5, 11, 12]. From an individual point of view, it is there-
fore not surprising that return to usual level of func-
tioning is considered by depressed individuals
themselves to be among the key facets defining remis-
sion from depression [13]. From a societal point of
view, the functional impairment in combination with
the high point prevalence of anxiety (7%) [14] and de-
pression (4%) [15], and typical early adulthood onset
[16], make these conditions immensely costly. Anxiety
and depression constitute two of the major causes of
burden of disease [17] and temporary and permanent
work-life absence among working-age adults [18–20].
Notably, though there is no clear evidence for a general
increase in prevalence of mental disorders, reports
across several Western countries show that their impact
on work absence is ever increasing [21–23].
While anxiety and depression are important causes for
work absence, there is strong evidence for work to have
a protective effect on mental health [24] and that un-
employment and sick leave itself can be detrimental for
health [25, 26]. Work gives access to monetary re-
sources, and may provide a daily structure, identity and
meaningful activities [27]. The workplace is also an
important arena for social inclusion for working-age
adults in modern society.
Finding measures to lower the burden of disease from
anxiety and depression and facilitate return to work and
work retention among people struggling with anxiety
and depression are therefore highly prioritized tasks
across many countries. Two major challenges need to be
solved in order to meet these goals. Firstly, there is a
huge gap between the numbers suffering from anxiety
and depression and the numbers seeking and receiving
minimal adequate treatment, both in Norway [28] and
globally [2, 29, 30]. Secondly, while there are substantial
evidence that psychological treatments, such as cognitive
behavioural therapy (CBT), have good effect on symp-
tom reduction and wellbeing [31, 32] the degree to
which such interventions have effect on functional and
work outcomes remain unsettled [33, 34]. There is not-
ably growing evidence that incorporating an explicit
work-focus in CBT treatments has a better effect on
work outcomes than CBT alone [32, 35, 36]. The picture
still is not clear-cut [37, 38] and few studies have in-
cluded longer-term follow-up [36].
Prompt Mental Health Care (PMHC, “Rask psykisk
helsehjelp” in Norwegian) was initiated by the Norwegian
Directorate of Health (NDH), as a means to improve ac-
cess to evidence-based care for adults with anxiety disor-
ders and subthreshold to moderate depression. PMHC is
based on the English, innovative program “Improving ac-
cess to psychological therapies” (IAPT) [39]. In short,
PMHC offers low-threshold, free-of-charge CBT-based
treatment. The treatment is organized according to a
matched care model including both low (guided self-help,
group-based psychoeducation) and high (individual CBT)
intensity treatment types [40]. Data from the 12 first
PMHC pilot sites have shown promising results in terms
of large improvements (effect sizes 1.0–1.2) in symptoms
of anxiety and depression from pre- to post treatment
[41]. The observed improvement was also largely main-
tained at 12months post-treatment [42].
Increased work participation is, second to alleviation
of symptoms, a key objective for the PMHC and IAPT
programs. In fact, gains achieved by reducing presentee-
ism and absenteeism were of the chief arguments used
for the cost-effectiveness of a large-scale roll-out of the
IAPT program [43, 44]. Several of the features of PMHC
and IAPT align well with the current evidence-base for
interventions to facilitate return to work and work par-
ticipation for people who struggle with anxiety and de-
pression. Firstly, early intervention might be decisive in
preventing long-term or permanent work-life exclusion.
For instance, time before beginning psychotherapy is
found to predict the length of sick leave when the vari-
ables age and duration of psychotherapy were controlled
[45]. Secondly, and reassuring for treatment models in-
cluding low-intensity care such as PMHC, a Cochrane
review found moderate quality evidence based on three
studies for telephone or online CBT to be more effective
in reducing sick leave than usual primary or occupa-
tional care among depressed people [35]. A stepped, pri-
mary care intervention for depression has also shown
small to moderate functional improvements at up to 3
months follow-up [46]. Nevertheless, as stated by
Thornicroft (2018), there still is little direct evidence that
the IAPT program in facts meet the goal of reducing
presenteeism and absenteeism [47].
When evaluating functional outcomes of an interven-
tion work status in combination with perceived func-
tional status can give crucial and complimentary
information. While work status is an important indicator
of economic independency and societal costs, this is only
one aspect of functioning. Perceived functional status
gives information about the subjective experience of
daily life functioning in a broader sense, both privately
and at work. Also, affected function is a criterion for a
formal mental disorder diagnosis. Such measures can
therefore be considered particularly informative, in
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addition to symptomatology, when evaluating low-
threshold interventions where no formal diagnosis is set,
as in PMHC. Finally, considering the many structural
factors impacting on work status, such as labour market
situation and benefit systems, but also cultural factors
like how mental disorders are perceived and treated at
workplaces [48], it is not given that the two measures
follow the same recovery path. For instance, in the
current focus on early return to work in Norway, a client
may have returned to work despite still experiencing im-
paired functionality.
Methods
Aims of the study
We aimed to examine the change in work participation
and functional status from pre- to post-treatment and
12months post-treatment among clients at the first 12
PMHC pilot sites, and whether any change differed
across gender, age groups, educational level and migra-
tion experience. While background variables such as age,
gender and education level are commonly investigated,
migration experience was included as 1) individuals with
such experience are underrepresented among PMHC cli-
ents [41], 2) it predicts less improvement in symptoms
of anxiety and depression during PMHC treatment [41],
and as 3) structural factors related to work participation
might affect individuals with migration experience differ-
ently than individuals born in Norway. If PMHC is
found to give improvement in functional and work sta-
tus also among individuals with migration experience,
this would further encourage working for a more inclu-
sive service.
Pilot samples and sampling procedure
The pilot sites and sampling procedures are described in
detail in previous publications [41, 49]. In short, the first
12 PMHC-pilot sites in Norway were established in
2012–2013 and distributed across several geographical,
both urban and rural, areas. Nine of the pilot sites were
located in individual municipalities, one through inter-
municipal cooperation and two covered boroughs in the
Oslo municipality. The population size and demographic
profiles of the pilot sites varied substantially [41, 49].
The PMHC teams had on average four full-time equiv-
alents independent of the catchment area population
size. As required by the Norwegian Directorate of Health
(NDH) guidelines, all teams were multidisciplinary and
had at least one clinical psychologist who carried the
professional responsibility for the services provided [40].
All therapists had individual treatment responsibilities.
All therapists had a minimum of 3 years with relevant
higher education, and completed an additional, mandatory
one-year training in cognitive behavioural therapy (CBT).
Work-focussed CBT was highlighted in the guidelines
from NDH as an overarching focus as a means to facilitate
return to work and sustainable work participation [40].
Two whole-day seminars during training focussed on how
to evaluate work capacity and conduct work-focussed
CBT.
The current study was conducted within routine care
at the PMHC pilot sites, and clients contacting the ser-
vices during the inclusion period were invited to partici-
pate. All clients first participated in an initial assessment.
During this session, information about the content and
treatment methodology within PMHC was provided. The
therapist also collected the necessary data to decide
whether PMHC could be the appropriate treatment, that
is the relevance and severity of mental problems, and the
available client resources, such as motivation for treat-
ment and social support. Participation in the study was
based on opt-in; clients who were suitable for treatment
were informed about the study, invited to participate and
asked to sign informed consent.
Inclusion criteria were being an inhabitant of the pilot
site community, ≥18 years of age, and having mental
health needs related to anxiety and/or depression (no
formal diagnosis was needed or provided). Therapists re-
ceived training in recognizing primary characteristics of
psychosis, bipolar disorder, personality disorder, severe
drug abuse, and suicide risk. Patients with a clear indica-
tion, or history, of these problems were generally ex-
cluded from PMHC, and referred to their GP or
secondary health care services.
Participants
In total, 2512 clients started treatment at one of the 12
PMHC pilot sites between October 2014 and December
2016. Of these, 1530 (61%) signed informed consent and
participated in the study.1 The study participation rate
varied between 27.7% in Orkdal to 79.3% in Oslo
Frogner. In 8 out of 12 pilot sites, the participation rate
was over 60%. Of the 1530 participants, 84.6% attended
at least two sessions. There were no fixed number of
sessions but an intended upper limit of 15 sessions. The
median number of scheduled meetings was 6.0 [41].
For the current study, we excluded those 67 years of
age and above (n = 22) or reporting having retired (n =
11), those reporting > 50% disability pension (n = 49) and
those doing military service (n = 2), ending up with a
sample of n = 1446 participating clients.
Data collection and measures
The participants were asked to complete questionnaires
before first treatment session, before each session during
1N = 1532 was previously reported (Knapstad et al. 2018) but two of
these turned out to be test cases and were therefore excluded from the
data file.
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the treatment, at post-treatment, and 12 months after
post-treatment. In over 97% of the cases, participants
completed the questionnaires electronically. For each
participant, therapists (n = 68) were asked to complete a
questionnaire at post-treatment about the therapy
process including degree of work focus in therapy.
Measures were selected to allow for comparison with
IAPT (incl. e.g. PHQ, GAD, WSAS) with an adaption to
the Norwegian context (e.g. work status questionnaire
fitting the Norwegian social security system).
Work status
Work status was self-reported and assessed by means of
two questions, one multi-response item about current
work status, and one multi-response item about sources
of income (see Additional file 1 for full questionnaire).
Based on these two questions, participants were placed
into three categories: 1) In regular work (part time or full
time), 2) In work and receiving benefits (i.e. fully or
graded sickness benefits, graded disability benefits), or 3)
Out of work, with or without benefits. Benefits included
sickness benefits, work assessment allowance, disability
pension, unemployment benefits, and financial assist-
ance. Students (n = 175) were categorized according to
their work status. “No work” included unemployment,
sheltered employment, disability pension, being a full-
time student or homemaker. A similar categorization
has been used in another Norwegian treatment study
[50] and in previous publications of the PMHC data
[41].
Functional status
The Work and Social Adjustment Scale (WSAS) [51]
was used to measure functional status. WSAS is a simple
5-item self-report measure, which assesses the impact of
a person’s mental health difficulties on their ability to
function in terms of work or studies, home management,
social leisure (activities together with others), private
leisure (activities done alone) and personal or family re-
lationships. For each domain the respondent is asked to
evaluate degree of impairment during last month on a
scale from 0 (not impaired) to 8 (severely impaired). A
sum score is calculated, ranging from 0 to 40, where
more impairment gives a higher score. The WSAS has
also been used for the evaluation of IAPT [39], and there
is some evidence that the WSAS in this context displays
discriminant validity and has comparable reliability and
sensitivity to change as the PHQ-9 and GAD-7 [52].
Socio-demographic factors
The following factors were included in descriptive statis-
tics and/or as potential moderators of change in work
and functional status over time: Gender, age-group (18-
30, 31-49, 50-66), educational level (primary-secondary
school, higher education), marital status (having a part-
ner, not having a partner), and migration experience (yes
or no; defined as self or both parents being born outside
Norway). All variables were self-reported at baseline.
Work-focus during treatment
At post-treatment the therapist reported degree of
work-focus during treatment on a five-level scale with
the response possibilities “very low”, “low”, “some”,
“high” and “very high”. A three-level variable was created
by merging the first two (very low and low) and latter
two (high and very high) categories, keeping the middle
category (some) unchanged.
Ethical considerations
The study was approved by the Regional Ethics Committee
for Western Norway (REK-vest no. 2014/597). Informed
consent was obtained from all participants, and all were
assured that they could withdraw from the study at any
time without any consequences for their further treatment.
Missing data
As previously described, missing questionnaire data were
generally low at baseline, but substantially higher at final
treatment and 12months post-treatment [41]. This was
also true for proportion of missing data regarding the
work status measure (1.0, 45.4, 63.1%) and WSAS (3.8,
46.7, 64.8%), respectively.
Missing data for both work status and WSAS were as-
sociated with baseline variables age group and educa-
tion level with ORs for missing ranging from 1.4–2.1 at
final treatment and 2.0–4.1 at 12 months post-treatment
for the youngest versus the oldest age group and lowest
versus highest educational level, respectively. Missing
WSAS data at final treatment were also borderline sig-
nificantly associated with higher baseline scores of PHQ
(OR 1.02), but not with baseline work status, GAD and
WSAS score. At 12 months-post-treatment, missing data
for work status was additionally weakly associated with
male gender (OR 1.3 (95%CI 1.0–1.7) and not having a
partner (OR 1.4 (95% CI 1.1–1.8)). Not having a partner
was also weakly related to missing data for WSAS at
final treatment (OR 1.3 (95% CI 1.0–1.5)) and 12 months
(OR 1.5 (95% CI 1.2–1.9)) as well as work status at final
treatment (OR 1.4 (95% CI 1.1–1.8)). Missing data for
WSAS were additionally related to baseline and final
treatment work status (n.s. and 0.7 for the in work and
receiving benefits group and 1.5 and 1.8 for the no work
group, compared to the regular work, no benefits group).
Missing data on work status at 12 months was neither
associated with baseline nor final treatment scores of
PHQ, GAD and WSAS.
There were moderate to strong correlations between
the observed values for both work status and WSAS at
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baseline and at final treatment (r = .65 and r = .48) and
12months post-treatment (r = .38 and r = .30), as well as
between final treatment and 12 months post-treatment
(r = .47 and r = .52). All other relevant baseline variables
(gender, age-group, educational level, marital status, mi-
gration experience, PHQ-score, and GAD-score) were
associated less strongly with the observed values of work
status and WSAS at post-treatment and 12-months
follow-up (r < .3). Note that all associations reported in
this section were tested for statistical significance at the
p < .05 level.
Taken together, the missing analyses gave some indi-
cations of data missing at random (MAR). However,
apart from the temporal autocorrelations for work status
and WSAS, the associations of baseline variables with
the observed values of work status and WSAS at post-
treatment and 12-months follow-up were relatively weak
(r < .4). Their impact as auxiliary variables would there-
fore be low [53].
It’s typical for these kinds of studies that missing data
is partly missing not at random (MNAR) as well. Some
of the bias introduced by MNAR may, however, be miti-
gated by including strong correlates of the variables with
missing data, which is accomplished in our case by in-
cluding baseline work status and WSAS in their respect-
ive linear mixed models adopting maximum likelihood
estimation [53].
Statistical analyses
Initially, descriptive statistics were conducted, to exam-
ine the PMHC samples’ overall work status at baseline,
as well as differences (chi squared tests) in work status
by central demographic characteristics (gender, age-
group, educational level, marital status and migration ex-
perience) and degree of work-focus during the course of
treatment.
Next, changes in work status and functional status as
measured by WSAS from pre- to post- treatment and
from post-treatment to 12months post-treatment were
investigated. First, the observed distribution of the work
status categories and mean (SD) of the WSAS score at
each of the three time points were calculated.
Change in work status was examined by means of
multilevel multinomial logit regression models based on
maximum likelihood (ML) estimation. Change in WSAS
score from baseline to final treatment and 12months
post-treatment were similarly examined using linear
mixed-effect regression models, also based on ML-
estimation. To account for cluster effects, pilot site was
included as a fixed effect in all regression models. ML-
estimation yields unbiased estimates under the assump-
tion of MAR and is generally accepted to provide less
biased estimates as compared to models that rely on
traditional methods for handling missing data (e.g. list-
wise deletion, last observation carried forward) [53].
To visualize the change in work status and WSAS,
predicted margins plots were created based on the
mixed-effect models (pilot site; fixed effect, repeated
measure on each individual; random effect). We also
created table plots to examine in more detail the distri-
bution of transitions between work statuses from base-
line to final treatment and from final treatment to 12
months post-treatment. Effect size of change in WSAS
score was calculated as estimated mean change/descrip-
tive SD at baseline.
It was also examined whether change over time in
work status and WSAS differed across gender, age-
group, educational level and migration experience. The
educational level variable was dichotomized (primary
and secondary school vs. higher education) to improve
power and hence increase robustness of the findings.
Likelihood ratio tests were performed to determine
whether the interaction between time and the respective
background variables were statistically significant. The
interaction effects were tested without specifying ran-
dom slopes for the time dummies as a result of identifi-
cation problems. As this may increase the risk for type-1
errors [54], interaction effects were only considered sta-
tistically significant at the p < .01 level.
All analyses were conducted using Stata versions 14.0
and 15.0 [55].
Results
Baseline description of the working age PMHC sample
Table 1 details the demographic characteristics and work
status of the working age sample from the 12 first
PMHC pilot sites. As previously reported [41, 49], and
also valid for this working-age sample, the PMHC par-
ticipants included a higher proportion of women, native
Norwegians and individuals with higher education com-
pared to the general working-age population in the
PMHC catchment areas. More than half of the sample
was in the age group 30–49 years old (51.7%), whereas
32.3% were in age group 18–29 and 16.0% in age group
50–66.
Looking at work status at baseline, 41.0% reported to
be in regular work, 38.1% in work and receiving benefits
(fully or graded), and 20.9% were out of work, with or
without benefits. Work status varied by demographic
characteristics; As for gender, whereas the proportion
out of work was similar between men and women, men
were more likely to be in regular work and women in
work and receiving benefits (χ2 = 21.9, df = 2, p < 0.001).
Being in regular work was more often reported in the
younger age groups, and among those having higher
education and natives, than among the older, and those
having lower education or migration experience (Table 1).
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Although the proportion out of regular work was found to
be markedly higher than in the general working popula-
tion, the relative differences in work status by the
mentioned sociodemographic characteristics are overall
commonly observed in general statistics and previous re-
search [56, 57].
Treatment characteristics related to work focus
As reported by the therapists, 29.8% of the treatments
provided included a high to very high work focus,
whereas 47.9% had some work focus and 22.3% little to
very little work focus. The degree of work focus was
higher in the treatments of those in work and receiving
benefits at baseline than the other groups (χ2 = 42.3, df =
4, p < 0.001) (see Table 1).
In the majority of treatments (71.0%), the therapists
reported no collaboration with external instances. Col-
laboration with the GP was reported for 16.5% and
Social Insurance Agency for 3.6% of the cases. Collabor-
ation with the GP and Social Insurance Agency were
more common in the groups not in regular work than in
the group in regular work at baseline (Table 1). Collabo-
rated directly with the client’s workplace was rare (0.4%
in total).
Change in work status from baseline to final treatment
and 12months post-treatment
As displayed in Table 2, the observed proportion in
regular work increased from baseline (40.0%) to final
treatment (51.2%), and had further increased at 12
Table 1 Demographic characteristics of PMHC sample by work status




No work, with or
without benefits
% (n) % % % Difference
Total 1446 41.0 38.1 20.9
Gender χ2 = 21.9, df = 2, p < 0.001
Men 25.0 (358) 50.4 28.6 21.0
Women 75.0 (1073) 37.8 41.4 20.8
Age group χ2 = 133.8, df = 4, p < 0.001
18–29 years 32.3 (462) 49.5 18.9 31.6
30–49 years 51.7 (741) 40.5 44.2 15.3
50–66 years 16.0 (229) 25.9 57.9 16.2
Educational level χ2 = 72.4, df = 4, p < 0.001
Primary school 10.0 (144) 25.0 29.2 45.8
Secondary school 45.0 (643) 42.1 36.3 21.6
Higher education 45.0 (643) 43.4 42.2 14.4
Marital status χ2 = 28.0, df = 2, p < 0.001
No partner 38.9 (555) 39.3 43.4 17.3
Having a partner 61.1 (873) 43.8 30.4 25.7
Migration exp. χ2 = 10.2, df = 2, p = 0.006
No 88.6 (1263) 42.3 38.0 19.7
Yes 11.4 (162) 32.9 37.3 29.8
Therapist-reported treatment characteristics (data completeness =75.1–78.2%)
Degree of work focus during therapy χ2 = 42.3, df = 4, p < 0.001
Very low-low 22.3 (242) 28.1 13.7 27.2
Some 47.9 (520) 47.3 47.4 50.0
High-very high 29.8 (324) 24.6 38.9 22.8
Collaborationa
No 71.0 (802) 79.8 67.9 58.2 χ2 = 36.8, df = 2, p < 0.001
GP 16.5 (186) 10.7 21.0 19.3 χ2 = 19.4, df = 2, p < 0.001
Social insurance 3.6 (41) 0.4 2.8 12.7 χ2 = 64.5, df = 2, p < 0.001
Work place 0.4 (5) 0.2 0.2 1.4 χ2 = 5.5, df = 2, p = 0.109
aMultiple responses allowed
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months post-treatment (63.6%). The observed propor-
tion among those in work and received benefits de-
creased over the same time period (38.1, 28.5, 16.1%,
respectively), whereas the proportion out of work seemed
rather stable (20.9, 20.3, 20.3%).
Results from the multilevel multinomial regression
models confirmed a clear and statistically significant im-
provement in work status, both from baseline to final
treatment and from final treatment to 12 months, from
work and receive benefits to regular work. More specific-
ally, setting regular work as base, the odds for work and
receive benefits at final treatment compared to baseline
was 0.38 [95% CI 0.29–0.50]. Further on comparing final
treatment to 12months post-treatment, the odds for
work and receive benefits was again substantially reduced
(OR 0.19 [95% CI 0.12–0.32]).
There was on the other hand no statistically significant
change in odds for out of work, neither when comparing
baseline to final treatment (OR 0.73 [95% CI 0.48–1.11]) nor
final treatment to 12months post-treatment (OR 0.76 [95%
CI 0.40–1.45]). Also here, regular work was set as base.
Figure 1 visualizes the predicted probability for each
work status category at baseline, final treatment and 12
months post-treatment. The graph again confirms the
increase in probability of regular work during follow-up,
a corresponding decrease in probability of work and re-
ceive benefits. The probability of being out of work,
hardly changed during follow-up. As expected, the ML-
based estimated probabilities under the assumption of
MAR are different from the observed probabilities pre-
sented in Table 1 under the assumption of MCAR. The
former indicated somewhat smaller changes at follow-
up. In Fig. 2, observed transitions between work statuses
from baseline and final treatment, and final treatment
and 12months post-treatment, respectively, are visual-
ized. The figure shows that there are considerably more
movement out of the work and receive benefits category
than the other categories, again indicating that the in-
crease in clients attaining regular work mainly is driven
by a reduction in those having work and receive benefits.
We performed a sensitivity analyses excluding students
(n = 175), since these as a group has looser work-life
attachment, specific health insurance arrangements and
“not working” for many equals their normal function as
students. The analyses excluding students provided simi-
lar results (results not shown).
Change in functional status by WSAS from baseline to
final treatment and 12months post-treatment
Regarding functional status, the descriptive statistics
(Table 2) suggest a substantial improvement in func-
tional status from baseline to final treatment, indicated
by a change in mean [95% CI] score of WSAS from
18.92 [18.44–19.40] to 10.61 [9.96–11.27]. At 12 months
post-treatment the observed mean WSAS score was still
substantially lower than at baseline (10.07 [9.19–10.94]).
The linear mixed model confirmed that the change in
WSAS score from baseline to final treatment was statis-
tically significant (b = − 8.11 [95% CI, − 8.74 – − 7.48],
p < 0.001), with a large effect size (ES − 0.89). The ob-
served change from pre- to post-treatment was main-
tained at 12-month post-treatment, as indicated by a
small ES-change (− 0.08) from final treatment to 12
months post-treatment (b = − 0.76 [95% CI, − 1.60 –
0.09], p = 0.080). Figure 3 visualizes and confirms the
substantial drop in mean predicted WSAS score from
baseline to final treatment, and that the change in score
levelled off onward to 12 months post-treatment.
Sensitivity analyses, excluding the n = 175 students
gave the overall same results, only displaying a minor re-
duction in estimated improvement in WSAS score at
final treatment (b = − 7.96 vs b = − 8.11 in total) and 12
months post-treatment (b = − 0.67 vs b = − 0.76 in total).
Table 2 Observed work status and functional status by WSAS over time
Baseline Final treatment 12months post-treatment
Work status n = 1432 n = 789 n = 533
In regular work, % 40.0 51.2 63.6
(95% CI) (38.5–43.6) (47.7–54.7) (59.4–67.6)
In work and receive benefits, % 38.1 28.5 16.1
(95%CI) (35.6–40.6) (25.5–31.8) (13.2–19.5)
Out of work, with or without benefits, % 20.9 20.3 20.3
(95%CI) (18.9–23.1) (17.6–23.2) (17.1–23.9)
WSASa n = 1391 n = 771 n = 509
Mean 18.92 10.61 10.07
(95% CI) (18.44–19.40) (9.96–11.27) (9.19–10.94)
aHigher WSAS score signifies more functional impairment (range 0–40)
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Change in work status and functional status by gender,
age, education level and migration experience
We did not find evidence for interaction effects between
time and any of the variables examined (gender, age,
education level and migration experience) for neither
work status nor WSAS score. For all these variables the
likelihood ratio (LR) tests did not meet the pre-specified
requirement of a p-value < 0.01.
Discussion
Main findings
A clear and substantial increase in regular work partici-
pation from pre- to post- treatment was observed among
the working-age clients at the 12 first PMHC pilot sites.
At 12 months after final treatment the proportion in
regular work had further substantially increased. This in-
crease was driven by a corresponding reduction in cli-
ents in work and receiving benefits, while there was no
statistically significant change over time in the group out
of work, with or without benefits. Regarding functional
status, a large improvement (effect size = −.89) was ob-
served from pre- to post-treatment, and was maintained
12months post-treatment. Although our study may have
had limited power to detect small differences (effect size
≲.3), our findings did indicate that the change in work
status and functional status over time did not differ to a
medium-to-large degree by the respective background
factors gender, age groups, educational level and migra-
tion experience.
Interpretation
Previous research has found a substantial improvement
in symptoms of anxiety and depression during PMHC
treatment [41, 58]. The current study shows that PMHC
is also associated with substantial improvement in work
and functional status from pre- to post-treatment and
12months post-treatment. Together, this puts weight to
the notion of PMHC being a viable alternative for help-
ing adults struggling with mild to moderate anxiety and
depression – with regards to symptom levels as well as
daily-life functioning and work participation. In light of
literature showing that functional impairment may con-
tinue also after symptom relief [5, 11, 12], it is highly
positive to observe that the strength of the pre-post im-
provement in functional status (− 0.9) is close to the ob-
served improvement in symptoms of depression (ES-1.1)
and anxiety (ES-1.0) in PMHC. Also, knowing that lon-
ger absences greatly reduces prospects for return to
work [59], observing the transition from receiving bene-
fits to full return to work is encouraging. The observed
increase in work participation may have great economic
impact, seen both from the individual and societal point
of view [60].
However, this study is based on a single-group, pre-post
design, and the lack of a control group precludes us from
evaluating to what extent the observed improvements are
attributable the PMHC treatment. Work status is a multi-
causal phenomenon decided by a range of interrelated fac-
tors, both proximal such as work ability and more distal
such as social security system, the composition of the
Fig. 1 Predicted probability of work status with 95%CI over time based on a multilevel multinomial logit regression model
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labour market and unemployment rates [61]. For instance,
some of the observed increase in work participation may
be driven by system incentives, such as reduced compen-
sation if sick-listed beyond 1 year. Related to this, cross-
country differences in benefit systems and how mental
disorders are perceived and treated at workplaces [48], as
well as cross-study differences in target populations,
makes it hard to find suitable benchmark samples.
Though the majority of individuals sick-listed with mental
disorders in general return to work within a year [62], a
range of factors [63], like long or recurrent absences [62,
64], older age [65] and severity and complexity of prob-
lems may greatly prolong time to return to work and in-
crease risk of permanent work disability, and may as such
limit the effect of PMHC treatment on these outcomes.
Thus, we do not know how many would improve their
work status also if not having received the PMHC treat-
ment. This limitation can only be addressed by comparing
outcomes between clients randomized to care in PMHC
or to treatment as usual. The on-going randomized con-
trolled trial in two new PMHC sites will be of great
interest, addressing the two main limitations of the
current study: treatment as usual will be provided to a
comparable control group, and problems with missing
data at follow-up will be avoided, as work status will be
extracted from complete, national registries (Clinical-
Trials.gov Identifier: NCT03238872).
Perceived functional status, though situated, may be less
affected by structural factors than actual work status. Nat-
ural recovery could of course still be an important alterna-
tive explanation for the observed improvement. Restricting
the analyses to those reporting having problems at least six
months prior to treatment (n = 1273) did, however, not
change effect size of change in functional status. As natural
recovery is less likely for individuals with long-lasting prob-
lems [66], and as improvement in psychosocial function
may lag behind clinical remission [5, 11, 12], at least some
of the observed improvement in functional status might be
a true benefit of the PMHC treatment. The observed effect
sizes of pre-to-post change in WSAS score of Cohens’ d =
− 0.89 is somewhat higher than our calculation of findings
from IAPT (Cohens’ d: mean pre-post change − 5.07/
Fig. 2 Table plots of transitions in work status from baseline to final treatment (upper figure) and from final treatment to 12months post-
treatment (lower figure)
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baseline SD 8.67 = 0.58) [52]. As previously discussed, direct
comparisons between IAPT and PMHC should be done
with caution [41], as there are differences in clinical popula-
tion, the treatment models, and in health care system more
broadly. Wait-list controls in RCTs in similar settings in-
cluding functional status outcomes can also serve as bench-
mark control condition. Few such studies could, however,
be identified. Among those identified as having fairly com-
parable target groups, follow-up times varied considerably.
With this in mind, the effect sizes of change in function
among the wait-list controls seemed to be in the small to
moderate range [67–70], i.e. lower than that observed
among the PMHC clients in the current study. Despite the
notable limitations to this study, the large and lasting im-
provement in functional status observed among PMHC cli-
ents in this study, can therefore be regarded as promising.
An interesting difference was seen in changes in work
status and functional status from final treatment to 12
months post-treatment; while functional status did not
change significantly post treatment, similar to previous
findings regarding symptoms of depression and anxiety
[42], the degree of work participation kept increasing.
One the one hand, it cannot be excluded that selective
attrition partly could explain the observed pattern. For in-
stance, those participating at 12months post-treatment
might have had better prerequisites (other than measured
through WSAS, PHQ or GAD) for returning to work than
those dropping out. On the other hand, it could also be ar-
gued that those having returned to work might have less
time to participate. Another conceivable interpretation is
that the observed pattern mirrors the natural course of re-
covery, were work participation temporally follow symp-
tom and functional improvement [71]. The continuing
improvement in work status post treatment could also
partly be an effect of the Norwegian sickness insurance
scheme, which for instance restrict fully compensated
sick-pay to one year. Disregarding of mechanism, the ob-
served “lagged effect” of work participation underscore the
importance of having longer-term follow-up in interven-
tion studies with occupational outcomes. Longer follow-
up may allow capturing both the whole recovery process,
which often takes longer for mental health than many
other conditions, and also the degree to which a sustain-
able work-life attendance is achieved [72].
It should be noted that though one in four of the
treatments were reported by therapists to have a high
degree of work focus, collaboration with the insurance
agency (3.6%) or the client’s workplace (0.4%) was rarely
reported. Even for individuals receiving benefits, collabor-
ation with other services was low. In the light of evidence
pointing towards service-coordination and workplace ac-
commodations as key components for helping workers
with mental health conditions back to work [73], it can be
questioned how work focus is implemented in the PMHC
context. Further studies should examine this in more
depth.
The proportion of clients out of work did hardly
change from pre- to post-treatment and 12months post-
treatment. At baseline this group was rather heteroge-
neous, consisting of unemployed (43%), people in
Fig. 3 Predicted mean functional status (WSAS) score with 95%CI over time, based on a linear mixed-effect model, adjusted estimates
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sheltered employment (31%), students (27%), home-
makers (16%), and people receiving part time (≤ 50%)
disability pension (6%) (some had combinations of these
statuses). Except for the unemployed, transition to regu-
lar work might not be a feasible or relevant treatment
goal. That said, in a Norwegian trial of work-focussed
CBT with individual job-support (AWaC), it was individ-
uals on long-term benefits at baseline only that showed
higher degree of work participation at follow-up [36].
Though the clinical populations in the PMCH and
AWaC services are not entirely comparable, one may
reason that those on long-term benefits are in particular
need of, and may especially profit from, a more compre-
hensive follow-up regarding work than provided within
the current frames of PMHC.
Regarding the findings of no significant interaction ef-
fects between time and any of the variables examined
(gender, age, education level and migration experience),
it is important to consider that the analyses examined
difference in change and not the absolute differences be-
tween the sub-groups. For instance, while there were no
difference in change in WSAS score between individuals
with and without migration experience, the former
group had markedly higher WSAS scores than the latter
at all three time points (data not shown). A previous
analysis of the PMHC data showed less improvement on
symptoms of anxiety and depression among individuals
with migration experience compared to those without
such experience [41]. It is therefore somewhat surpris-
ing, and encouraging, that change in functional status
did not differ between these groups. As older age is asso-
ciated with increased risk of non-return to work [57,
65], it was also unexpected to find no significant differ-
ences in change by age groups. The relatively low cut-off
at 50 years for oldest age-group and very few clients in
the oldest age range in the current study might explain
this null-finding.
Strengths and limitation
Strengths of the current study include the multi-centre
and naturalistic design, increasing generalizability of the
findings; the inclusion of both functional and work
status outcomes, yielding complimentary information
about degree of functioning following the PMHC treat-
ment; the use of measures included in previous studies
of related samples (WSAS in the IAPT evaluations, work
participation measure used in the AWaC studies) facili-
tating comparability across studies; the relatively long
term follow-up of 12 months following final treatment.
The most important limitation is the lack of a control
group, which, as discussed above, make it difficult to
evaluate to what extent the improvement in work and
functional status is attributable to the PMHC treatment.
Secondly, the high rates of missing data at post-
treatment and 12months post-treatment, may also have
biased the results as discussed above and in the method
section. While the degree of bias is difficult to fully as-
certain, the use of state-of-the-art methods to deal with
missing data is a compensating strength. The relatively
strong temporal associations observed for work status
and WSAS could partly eliminate the bias introduced by
a potential missing not at random (MNAR) situation
when using full information maximum likelihood
(FIML). Finally, as transitions between work participa-
tion and absence can be a dynamic and gradual process
[61], pre-post measures might not have fully captured
important nuances in the in- or outflow from work.
Conclusion
Traditionally, clinical trials tend to focus on degree of
symptom improvement as its key success criterion [74].
If we indeed intend to sustainably lower the burden of
anxiety and depression, we need, however, also to stress
the degree to which an intervention succeed in restoring
or improving the individuals’ capability to function in
their ordinary, daily lives. Symptomatic improvement
following the PMCH treatment is previously reported
[41, 58]. The current study adds to this knowledge by
showing that PMHC treatment is also associated with a
substantial and lasting improvement in daily life func-
tioning. Moreover, a considerable amount of clients
moved from receiving benefits to work. The degree to
which the observed improvements are attributable to the
treatment provided need to be confirmed in a trial in-
cluding a control group, and, ideally, with complete
follow-up data from registries. Until then, the present re-
sults should be regarded as promising with regard to the
effects of PMHC on work participation and functional
status.
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